Jun 9, 2026 07:30AM
May 15, 2026 07:33AM
May 7, 2026 04:24PM
Apr 20, 2026 07:30AM
Apr 17, 2026 04:34AM
Apr 13, 2026 05:52AM
Mar 13, 2026 08:51AM Corvus Pharma (CRVS) files mixed shelf
Mar 13, 2026 07:23AM
Mar 13, 2026 06:26AM
Mar 12, 2026 04:02PM
Jan 23, 2026 07:23AM
Jan 22, 2026 12:22PM
Jan 21, 2026 07:07AM
Jan 20, 2026 06:09PM Corvus Pharmaceuticals (CRVS) PT Raised to $32 at Oppenheimer
Jan 20, 2026 04:26PM
Jan 20, 2026 12:30PM
Dec 11, 2025 06:52AM
Nov 4, 2025 04:17PM
Oct 13, 2025 05:30AM
Aug 7, 2025 04:13PM
Jun 25, 2025 08:02AM Corvus Pharma (CRVS) Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
Jun 25, 2025 06:36AM
Jun 12, 2025 07:23AM
Jun 4, 2025 07:01AM
May 20, 2025 05:33AM
May 12, 2025 05:59AM
May 8, 2025 04:14PM
May 8, 2025 04:03PM Corvus Pharmaceuticals, Inc. (CRVS) Misses Q1 EPS by 1c
Apr 9, 2025 04:02PM
Mar 26, 2025 06:49AM
Mar 25, 2025 04:01PM
Mar 20, 2025 08:03AM
Mar 12, 2025 08:01AM
Jan 13, 2025 07:30AM
Dec 23, 2024 05:34AM Increasing unusual call option volume: QUBT XND AMCR CRVS MVST ARQT AMTM CNC CE JCI
Dec 19, 2024 06:38AM
Dec 18, 2024 08:08AM
Dec 18, 2024 07:33AM
Dec 18, 2024 07:30AM
Dec 17, 2024 04:49PM
Dec 17, 2024 04:01PM
Dec 4, 2024 04:06PM Corvus Pharma (CRVS) Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib
Nov 14, 2024 10:01AM
Nov 13, 2024 01:24PM
Nov 12, 2024 04:03PM
Oct 22, 2024 06:05AM
Sep 16, 2024 06:48AM
Sep 10, 2024 08:31AM
Aug 16, 2024 02:59PM Mizuho Reiterates Neutral Rating on Corvus Pharmaceuticals (CRVS)
Aug 6, 2024 04:05PM

404,872 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All